The Gastrointestinal Drugs Advisory Committee of the FDA met to discuss the safety/efficacy of Intercept Pharmaceuticals' (NASDAQ: ICPT) Ocaliva (obeticholic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE